InTandem Capital Partners Invests in Clinilabs
March 12, 2025
InTandem Capital Partners has made a strategic growth investment in Clinilabs, a global full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug and device development. The partnership with Clinilabs’ founder and management will support scaling the company’s neuroscience trial capabilities across Phase 1–3 and accelerate commercial and operational growth.
- Buyers
- InTandem Capital Partners
- Targets
- Clinilabs
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.